ArticleBMC gastroenterology2021

Risk and characteristics of tuberculosis after anti-tumor necrosis factor therapy for inflammatory bowel disease: a hospital-based cohort study from Korea.

Jae Yong Lee et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.